Currently out of the existing stock ratings of Gregg Gilbert, 153 are a BUY (72.51%), 55 are a HOLD (26.07%), 3 are a SELL (1.42%).

Gregg Gilbert

Work Performance Price Targets & Ratings Chart

Analyst Gregg Gilbert, currently employed at TRUIST, carries an average stock price target met ratio of 61.5% that have a potential upside of 31.38% achieved within 326 days.

Gregg Gilbert’s has documented 439 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Energy sectors.

Most recent stock forecast was given on COLL, Collegium Pharmaceutical at 07-Aug-2025.

Wall Street Analyst Gregg Gilbert

Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.

Average potential price target upside

of $31.63 (23.35%) on LLY (ELI LILLY AND COMPANY).
of $28.17 (66.3%) on ABBV (ABBVIE).
of $27.1 (41.82%) on MRK (MERCK MPANY).

ABBV AbbVie AGN Allergan plc AKRX Akorn AMAG AMAG Pharmaceuticals ARQT Arcutis Biotherapeutics ATRS Antares Pharma BHC Bausch Health Companies ENDP Endo International PLC EOLS Evolus JAZZ Jazz Pharmaceuticals PLC LCI Lannett Company LGND Ligand Pharmaceuticals LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MYL Viatris NVCR Novocure Ltd PFE Pfizer PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis BMY Bristol-Myers Squibb Company COLL Collegium Pharmaceutical AMRX Amneal Pharmaceuticals, Common Stock VTRS Viatris SGNT Sagent Pharmaceuticals DHT DHT Holdings AERI Aerie Pharmaceuticals PCRX Pacira Pharmaceuticals ACT Enact Holdings AM Antero Midstream Partners LP CHRS Coherus BioSciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Trung Huynh (RBC)